- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04280016
The Effect of Exercise on Wound Healing While Off-loading
The Effect of Exercise on Wound Healing in People With Diabetes Undergoing Off-loading Treatment
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The purpose of this project is to establish the effect of the addition of exercise to an off-loading intervention on the healing time for people with diabetes mellitus and a foot ulcer.
While benefits of physical activity and exercise are clear, the benefit of exercise on wound healing in individuals with diabetes has not been elucidated. It is critical to better understand how prescribed exercise effects the healing speed in patients receiving wound care with appropriate off-loading. If exercise does decrease healing time, the benefit to the patient may include lower cost, decreased risk of infection, decreased burden on a caregiver, and improved quality of life.
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Deborah M. Wendland, PhD
- Número de telefone: 6785476775
- E-mail: wendland_dm@mercer.edu
Estude backup de contato
- Nome: Teri Biven, DPT
- Número de telefone: 404.605.2743
- E-mail: Teri.Biven@piedmont.org
Locais de estudo
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30309
- Recrutamento
- Piedmont Healthcare
-
Contato:
- Teri Biven, DPT
- Número de telefone: 404-605-2743
- E-mail: Teri.Biven@piedmont.org
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Have diabetes
- Have an active plantar ulceration
- With or without peripheral neuropathy
- Able to safely exercise
- Receiving care for their plantar ulceration, including off-loading
Exclusion Criteria:
- Presence of an untreated infection, osteomyelitis, or gangrene
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Exercise Added to Off-loading
Participants in this arm will participate in exercise at the healthcare facility one time a week (away from where wound care is provided) and be instructed in a home exercise program that they will be encouraged to perform at least three days per week with no more than two days between sessions.
Wound care will continue at the facility as is standard, utilizing off-loading.
|
Participants will participate in an exercise session with non-weight-bearing exercise that the participant is able to perform with off-loading (e.g. total contact cast) intact.
They will also be instructed in a home exercise program so that exercise can be performed three days per week with no more than two days between sessions.
These participants will also receive standard wound care with off-loading.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Wound measurement size
Prazo: Measurements of wound will be taken up to 12 weeks or until wound closure occurs, whichever is first.
|
Charts will be reviewed for normal wound measurements as is part of standard care.
Measurements are expected to be reported as surface area (cm^2) and/or volume (cm^3).
Wound closure will be defined as epithelialization across the entire wound bed and would be expected to correlate to no surface area or volume of wound being reported.
|
Measurements of wound will be taken up to 12 weeks or until wound closure occurs, whichever is first.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Summary of Diabetes Self-Care Activities Scale
Prazo: Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
Participation in exercise.
Using two questions, this scale measures the number of days that an individual reports doing physical activity (question 1) or specific exercise (question 2).
Scores on each question could range from 0 to 7 days.
The higher the number, the more days the individual participates in the activity or exercise.
|
Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
|
Body Mass Index
Prazo: Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
Height and weight measurements will be combined and reported as BMI and measured in kg/m^2.
|
Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
|
Physical activity data using an activity monitor (e.g. StepWatch).
Prazo: Measured at baseline for one week.
|
A week-long measurement of strides will be taken at the begin of the study.
|
Measured at baseline for one week.
|
|
Vibration sense
Prazo: Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
Vibration sense will be measured using a Bio-Thesiometer to assess for degree of peripheral neuropathy.
A higher score would indicate decreased sensory perception of vibration.
|
Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
|
Waist circumference
Prazo: Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
Waist circumference will be taken in cm as a marker of body composition.
|
Measurement will be taken at baseline and at end of study (at 12 weeks or at wound closure, whichever occurs first).
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Deborah M. Wendland, Mercer University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- H1908192
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .